Cabotegravir

Cabotegravir is an antiretroviral medication used to treat or prevent HIV/AIDS. It is available as oral tablets (Vocabria) or as a long-acting intramuscular injection—either alone (Apretude) for PrEP or with Rilpivirine (Cabenuva) for HIV treatment. It reduces HIV risk by 79% compared to daily oral PrEP.